Through in-house engineering activities, InnoMedica transfers products from research to GMP production and develops new processes. Streamlined workflows and a modular infrastructure enable InnoMedica to quickly scale up production capacity efficiently.
As part of its scale-up projects, InnoMedica investigates the necessary formulation and product adjustments to enable the reproducible production of liposomal products at larger volumes. With the expansion of the Nanofactory, InnoMedica not only ensures the supply for clinical trials but also establishes the foundation for future production volumes required for larger studies or market entry.
Key processes, including manufacturing, quality control, and filling, are largely automated. For the filling of clinically applicable vials, InnoMedica has developed its own filling robots in collaboration with universities and industry partners. This solution was deliberately chosen, as outsourcing would not only be significantly more expensive but would also result in the loss of critical technical expertise outside the company.
By designing these custom-built systems, InnoMedica can invest cost-effectively, tailor processes to the specific needs of nanomedicine, and build technical knowledge in-house. The combination of automation, flexibility, and engineering expertise lays the foundation for scalable, robust production that is prepared for future demands.
